Profit in the time of pandemic: How Big Pharma benefitted from the COVID-19 crisis, and why the TRIPS agreement should be scrapped

By APRN | November 30, 2021

The world is in dire need of vaccines. Close to two years into the coronavirus crisis, the global death toll has reached 5 million. Deaths are feared to be higher than recorded. Despite expedited development of vaccines for COVID-19, access to them remains limited, especially for low and middle-income countries. The monopoly of big pharmaceutical companies over vaccine production and supply hampers access among  poorer nations. More lives are lost, when vaccines could have saved them.

Download here: []

To top